F2 and Cirrhosis: The European Association for the Study of the Liver (EASL) explicitly discourages routine administration of vitamin K in patients with cirrhosis, noting that prolonged prothrombin time (PT) in this population primarily reflects impaired hepatic synthesis of both vitamin K–dependent and –independent clotting factors, rather than a reversible vitamin deficiency [17].